Chenguang Biotech Group (300138) — Capital Reinvestment Ratio
Chenguang Biotech Group (300138) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥524.96 Million) in capital expenditures (CN¥37.63 Million). See 300138 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chenguang Biotech Group Capital Reinvestment Ratio (2008–2022)
This chart tracks Chenguang Biotech Group's Capital Reinvestment Ratio across 7 annual periods. Check 300138 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Chenguang Biotech Group (2008–2022)
Year-by-year Capital Reinvestment Ratio for Chenguang Biotech Group from 2008 to 2022. For live market cap and broader valuation context, see how much is Chenguang Biotech Group worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.24x | CN¥734.81 Million | CN¥176.03 Million | ▼ -94.5% |
| 2021 | 4.39x | CN¥63.90 Million | CN¥280.82 Million | ▲ +432.5% |
| 2020 | 0.83x | CN¥529.41 Million | CN¥436.88 Million | ▲ +515.0% |
| 2014 | 0.13x | CN¥272.96 Million | CN¥36.62 Million | ▼ -93.9% |
| 2011 | 2.21x | CN¥82.18 Million | CN¥181.72 Million | ▼ -10.0% |
| 2009 | 2.46x | CN¥27.23 Million | CN¥66.90 Million | ▼ -14.5% |
| 2008 | 2.87x | CN¥9.06 Million | CN¥26.05 Million | — |